BackLipella Pharmaceuticals Overview

Lipella Pharmaceuticals Long Term Debt

Lipella Pharmaceuticals's long-term debt is $220M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$219.82M

Peer trimmed avg / median

Loading

Lipella Pharmaceuticals Long Term Debt History

Loading

Lipella Pharmaceuticals vs. peers: Long Term Debt Comparison

Loading

Lipella Pharmaceuticals Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lipella Pharmaceuticals (LIPO) FAQ

Lipella Pharmaceuticals (LIPO) currently reports a long-term debt of $220M as of September 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Lipella Pharmaceuticals's long-term debt history and peer comparisons.

Lipella Pharmaceuticals's long-term debt changed from $0 to $220M (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lipella Pharmaceuticals reported $220M in long-term debt as of September 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lipella Pharmaceuticals, and consider following LIPO for alerts when major investors trade the stock.